KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $926,873 | +10157.6% | 78,682 | +7736.9% | 0.00% | – |
| Q2 2023 | $9,036 | +14.5% | 1,004 | 0.0% | 0.00% | – |
| Q1 2023 | $7,891 | +16.3% | 1,004 | 0.0% | 0.00% | – |
| Q4 2022 | $6,787 | -51.5% | 1,004 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | -94.3% | 1,004 | -94.6% | 0.00% | – |
| Q4 2021 | $247,000 | -24.2% | 18,705 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $326,000 | -27.2% | 18,705 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $448,000 | -6.7% | 18,705 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $480,000 | +12.9% | 18,705 | -16.8% | 0.00% | 0.0% |
| Q4 2020 | $425,000 | -72.1% | 22,486 | -81.4% | 0.00% | -66.7% |
| Q3 2020 | $1,521,000 | – | 120,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,579,490 | $20,146,000 | 22.25% |
| Novo Holdings A/S | 2,901,927 | $22,664,000 | 2.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 322,436 | $2,518,000 | 0.96% |
| Vivo Capital, LLC | 300,325 | $2,346,000 | 0.69% |
| VHCP Management II, LLC | 221,651 | $1,635,000 | 0.67% |
| RA Capital Management | 591,070 | $4,616,000 | 0.57% |
| INTERWEST VENTURE MANAGEMENT CO | 329,942 | $2,577,000 | 0.55% |
| Eventide Asset Management | 98,100 | $766,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 21,665 | $169,000 | 0.03% |
| A.R.T. Advisors, LLC | 11,116 | $86,000 | 0.00% |